390 related articles for article (PubMed ID: 33661858)
1. Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns.
Huang G; Zhang J; Gong L; Liu D; Wang X; Chen Y; Guo S
Med Sci Monit; 2021 Mar; 27():e929524. PubMed ID: 33661858
[TBL] [Abstract][Full Text] [Related]
2. Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma.
Li XS; Nie KC; Zheng ZH; Zhou RS; Huang YS; Ye ZJ; He F; Tang Y
BMC Cancer; 2021 Jan; 21(1):96. PubMed ID: 33485313
[TBL] [Abstract][Full Text] [Related]
3. A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis.
Yang K; Wu Y
BMC Cancer; 2021 Feb; 21(1):128. PubMed ID: 33549049
[TBL] [Abstract][Full Text] [Related]
4. Integrative analysis of DNA methylation-driven genes for the prognosis of lung squamous cell carcinoma using MethylMix.
Li R; Yin YH; Jin J; Liu X; Zhang MY; Yang YE; Qu YQ
Int J Med Sci; 2020; 17(6):773-786. PubMed ID: 32218699
[No Abstract] [Full Text] [Related]
5. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
Yang Y; Wang M; Liu B
J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
[TBL] [Abstract][Full Text] [Related]
6. Identification of Specific Candidate Diagnostic Biomarkers for Lung Squamous Cell Carcinoma Based on Methylation.
Wang X; Wang X; Li X; Chang Y
J Comput Biol; 2020 May; 27(5):825-833. PubMed ID: 31486674
[TBL] [Abstract][Full Text] [Related]
7. Multiple mutations of lung squamous cell carcinoma shared common mechanisms.
Li Q; Hou J; Hu Z; Gu B; Shi Y
Oncotarget; 2016 Nov; 7(48):79629-79636. PubMed ID: 27835590
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas.
Gao C; Zhuang J; Zhou C; Ma K; Zhao M; Liu C; Liu L; Li H; Feng F; Sun C
J Cell Physiol; 2019 May; 234(5):6519-6528. PubMed ID: 30246311
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
Ke D; Guo Q; Fan TY; Xiao X
Cancer Biother Radiopharm; 2021 Apr; 36(3):280-291. PubMed ID: 33112657
[No Abstract] [Full Text] [Related]
10. Role of downregulated ADARB1 in lung squamous cell carcinoma.
Wang X; Ren X; Liu W; Chen X; Wei J; Gong Z; Yan Y; Xu Z
Mol Med Rep; 2020 Mar; 21(3):1517-1526. PubMed ID: 32016472
[TBL] [Abstract][Full Text] [Related]
11. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma.
Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J
DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870
[TBL] [Abstract][Full Text] [Related]
12. A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma.
Huang G; Zhang J; Gong L; Huang Y; Liu D
BMC Cancer; 2021 May; 21(1):626. PubMed ID: 34044809
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
14. An integrative investigation on significant mutations and their down-stream pathways in lung squamous cell carcinoma reveals CUL3/KEAP1/NRF2 relevant subtypes.
Liu Z; Deng M; Wu L; Zhang S
Mol Med; 2020 May; 26(1):48. PubMed ID: 32434476
[TBL] [Abstract][Full Text] [Related]
15. Multi-omics analysis at epigenomics and transcriptomics levels reveals prognostic subtypes of lung squamous cell carcinoma.
Xu Y; She Y; Li Y; Li H; Jia Z; Jiang G; Liang L; Duan L
Biomed Pharmacother; 2020 May; 125():109859. PubMed ID: 32036209
[TBL] [Abstract][Full Text] [Related]
16. Predicting the Lung Squamous Cell Carcinoma Diagnosis and Prognosis Markers by Unique DNA Methylation and Gene Expression Profiles.
Wang W; Wang S; Chu X; Liu H; Xiang M
J Comput Biol; 2020 Jul; 27(7):1041-1054. PubMed ID: 31710242
[TBL] [Abstract][Full Text] [Related]
17. A low DNA methylation epigenotype in lung squamous cell carcinoma and its association with idiopathic pulmonary fibrosis and poorer prognosis.
Hata A; Nakajima T; Matsusaka K; Fukuyo M; Morimoto J; Yamamoto T; Sakairi Y; Rahmutulla B; Ota S; Wada H; Suzuki H; Matsubara H; Yoshino I; Kaneda A
Int J Cancer; 2020 Jan; 146(2):388-399. PubMed ID: 31241180
[TBL] [Abstract][Full Text] [Related]
18. Differential
Lin S; Tian C; Li J; Liu B; Ma T; Chen K; Gong W; Wang JM; Huang J
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786615
[TBL] [Abstract][Full Text] [Related]
19. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH
Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443
[TBL] [Abstract][Full Text] [Related]
20. DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma.
Wang X; Huang Z; Li L; Wang G; Dong L; Li Q; Yuan J; Li Y
BMC Cancer; 2022 Aug; 22(1):866. PubMed ID: 35941578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]